DCTA vs. IOF, HAYD, WCH, ITX, HDD, BIOM, ESKN, AGM, VRS, and ZED
Should you be buying Directa Plus stock or one of its competitors? The main competitors of Directa Plus include Iofina (IOF), Haydale Graphene Industries (HAYD), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Hardide (HDD), Biome Technologies (BIOM), Esken (ESKN), Applied Graphene Materials (AGM), Versarien (VRS), and Zenova Group (ZED). These companies are all part of the "specialty chemicals" industry.
Directa Plus vs. Its Competitors
Iofina (LON:IOF) and Directa Plus (LON:DCTA) are both small-cap basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.
Iofina has a net margin of 6.98% compared to Directa Plus' net margin of -48.00%. Iofina's return on equity of 8.00% beat Directa Plus' return on equity.
In the previous week, Iofina's average media sentiment score of 0.75 beat Directa Plus' score of 0.00 indicating that Iofina is being referred to more favorably in the media.
6.4% of Iofina shares are owned by institutional investors. Comparatively, 20.5% of Directa Plus shares are owned by institutional investors. 45.1% of Iofina shares are owned by insiders. Comparatively, 57.9% of Directa Plus shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Iofina has higher revenue and earnings than Directa Plus. Directa Plus is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.
Iofina has a beta of 0.71, suggesting that its share price is 29% less volatile than the S&P 500. Comparatively, Directa Plus has a beta of 0.74, suggesting that its share price is 26% less volatile than the S&P 500.
Iofina presently has a consensus target price of GBX 37.50, suggesting a potential upside of 50.00%. Given Iofina's stronger consensus rating and higher probable upside, equities research analysts clearly believe Iofina is more favorable than Directa Plus.
Summary
Iofina beats Directa Plus on 12 of the 15 factors compared between the two stocks.
Get Directa Plus News Delivered to You Automatically
Sign up to receive the latest news and ratings for DCTA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding DCTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Directa Plus Competitors List
Related Companies and Tools
This page (LON:DCTA) was last updated on 8/23/2025 by MarketBeat.com Staff
MarketBeat All Access